IDI&CA_COLITIS/2019 - Pharmacological modulation of inflammation associated with inflammatory bowel disease: a model of chronic experimental colitisChronic inflammatory disease of the gastrointestinal (GI) tract characterized by recurrent ulceration. Treatment of inflammatory bowel disease induce and maintain the patient in remission However do not modify or reverse the underlying pathogenic mechanism. Nonclinical studies for emerging therapeutic strategies. Aim of the study: Evaluate the efficacy of new drugs in inflammatory bowel disease through an animal model of TNBS-induced chronic colitis.N/
The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute inflammatory bowel disease (IBD) model i...
Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to...
A number of models of spontaneous chronic intestinal inflammation in mice and rats have recently bee...
Background: Inflammatory bowel disease (IBD) is a world healthcare problem. In order to evaluate the...
IDI&CA_IPL/2019/COLITiS_ESTeSLFCT_UIDB/05608/2020. FCT_UIDP/05608/2020.Background: Inflammatory bowe...
Background: Despite recent advances the pathogenesis of Crohn's disease remains incompletely underst...
Inflammatory bowel disease (IBD) is a chronic multifactorial inflammatory disorder characterized by ...
Inflammatory bowel disease (IBD) is a chronic multifactorial inflammatory disorder characterized by ...
Background/Aims: Inflammatory bowel diseases (IBD) are chronic relapsing diseases of unknown origin...
IDI&CA_COLITIS/2019Inflammatory bowel disease includes Crohn's disease and ulcerative colitis. Chron...
Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a lifelong d...
Inflammatory Bowel Diseases (IBD) are life-threatening chronic and relapsing disorders of the immune...
Inflammatory bowel disease (IBD) represents a chronic, relapsing, remitting, and inflammatory condit...
Summary. Background: There is no standard practice in the induction of colitis by 2,4,6-trinitrobenz...
Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to...
The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute inflammatory bowel disease (IBD) model i...
Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to...
A number of models of spontaneous chronic intestinal inflammation in mice and rats have recently bee...
Background: Inflammatory bowel disease (IBD) is a world healthcare problem. In order to evaluate the...
IDI&CA_IPL/2019/COLITiS_ESTeSLFCT_UIDB/05608/2020. FCT_UIDP/05608/2020.Background: Inflammatory bowe...
Background: Despite recent advances the pathogenesis of Crohn's disease remains incompletely underst...
Inflammatory bowel disease (IBD) is a chronic multifactorial inflammatory disorder characterized by ...
Inflammatory bowel disease (IBD) is a chronic multifactorial inflammatory disorder characterized by ...
Background/Aims: Inflammatory bowel diseases (IBD) are chronic relapsing diseases of unknown origin...
IDI&CA_COLITIS/2019Inflammatory bowel disease includes Crohn's disease and ulcerative colitis. Chron...
Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a lifelong d...
Inflammatory Bowel Diseases (IBD) are life-threatening chronic and relapsing disorders of the immune...
Inflammatory bowel disease (IBD) represents a chronic, relapsing, remitting, and inflammatory condit...
Summary. Background: There is no standard practice in the induction of colitis by 2,4,6-trinitrobenz...
Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to...
The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute inflammatory bowel disease (IBD) model i...
Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to...
A number of models of spontaneous chronic intestinal inflammation in mice and rats have recently bee...